TRX BIOSCIENCES LIMITED

Updated 34 days ago
Private Limited Company
  • Active - 11986839 (CH)
  • Age: 4 years
  • ID: 49842740/15
THE WALBROOK BUILDING 25 WALBROOK LONDON ENGLAND EC4N 8AF
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
TRX's technology enables targeted oral drug delivery to specific organs, cells and tissues in cancer, CNS and respiratory diseases and diseases of the immune system using a clinically and developmentally proven approach... A disruptive advancement in oral drug uptake, trafficking therapeutics directly to the site of disease, reducing the impact of first-pass metabolism and enhancing production of regulatory immune cells. TRx is leveraging these and other benefits across a growing portfolio of co-development and wholly-owned programmes.
Also known as: TRx Biosciences
Previous names: INFIRST (US HOLDINGS) LIMITED
Registration numbers: 11986839 (CH)
Primary location: LONDON ENGLAND
  • 0
  • 0
Interest Score
1
HIT Score
0.20
CEO
Dr Robin Bannister
CSO
John Brew
Founder
Dr Robin Bannister, John Brew

UK Company Data

Company number
11986839		 Account category
TOTAL EXEMPTION FULL		 Account ref. day
31		 Account ref. month
12
Accounts next due date
2024-09-30		 Accounts last made up date
2022-12-31		 Returns next due date
2020-06-06		 Returns last made up date
N/A
Num. mort. charges
0		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
0
Num. gen. partners
0		 Num. lim. partners
0
Domain
trxbiosciences.com
Actual
www.trxbiosciences.com
IP
185.199.220.84
Status
OK
Category
Company
0 comments Add a comment